176 related articles for article (PubMed ID: 24986483)
21. Hypokalemia and hypomagnesaemia related to levetiracetam use.
Aksoy D; Cevik B; Kurt S; Pekdas E; Solmaz V
J Clin Neurosci; 2014 Nov; 21(11):1989-90. PubMed ID: 24906211
[TBL] [Abstract][Full Text] [Related]
22. Levetiracetam may worsen myoclonus in patients with juvenile myoclonic epilepsy: case reports.
Babtain FA
Clin Neuropharmacol; 2012; 35(4):201-2. PubMed ID: 22805231
[TBL] [Abstract][Full Text] [Related]
23. [Successful treatment of epilepsy and circadian rhythm disturbance with levetiracetam in a patient with dentatorubral-pallidoluysian atrophy (DRPLA)].
Hamada S; Shimakawa S; Satomura S; Naito E; Hashimoto T
No To Hattatsu; 2014 Nov; 46(6):439-42. PubMed ID: 25558587
[TBL] [Abstract][Full Text] [Related]
24. Levetiracetam induced acute reversible psychosis in a patient with uncontrolled seizures.
Kumar N; Swaroop HS; Chakraborty A; Chandran S
Indian J Pharmacol; 2014; 46(5):560-1. PubMed ID: 25298593
[TBL] [Abstract][Full Text] [Related]
25. [Therapeutic drug monitoring of levetiracetam].
Dailly E; Bouquié R; Bentué-Ferrer D;
Therapie; 2010; 65(1):67-70. PubMed ID: 20205999
[TBL] [Abstract][Full Text] [Related]
26. Catatonia induced by levetiracetam.
Chouinard MJ; Nguyen DK; Clément JF; Bruneau MA
Epilepsy Behav; 2006 Feb; 8(1):303-7. PubMed ID: 16249124
[TBL] [Abstract][Full Text] [Related]
27. Levetiracetam: preliminary efficacy in generalized seizures.
Kasteleijn-Nolst Trenité DG; Hirsch E
Epileptic Disord; 2003 May; 5 Suppl 1():S39-44. PubMed ID: 12915340
[TBL] [Abstract][Full Text] [Related]
28. The SKATE study: interim analysis.
Olwen GO
Int J Clin Pract; 2003; 57(6):544-5. PubMed ID: 12918896
[TBL] [Abstract][Full Text] [Related]
29. Levetiracetam-associated aggravation of myoclonic seizure in children.
Liu YH; Wang XL; Deng YC; Zhao G
Seizure; 2012 Dec; 21(10):807-9. PubMed ID: 22990039
[TBL] [Abstract][Full Text] [Related]
30. [Levetiracetam in the treatment of epilepsy].
Mariero Klees T; Brodtkorb E; Nakken KO; Lossius R; Johannessen SI
Tidsskr Nor Laegeforen; 2003 May; 123(11):1539-41. PubMed ID: 12822020
[TBL] [Abstract][Full Text] [Related]
31. Haemodialysis significantly reduces serum levetiracetam levels inducing epileptic seizures: Case report.
Company-Albir MJ; Ruíz-Ramos J; Solana Altabella A; Marqués-Miñana MR; Vicent C; Poveda JL
J Clin Pharm Ther; 2017 Dec; 42(6):774-775. PubMed ID: 28555936
[TBL] [Abstract][Full Text] [Related]
32. The risk of paradoxical levetiracetam effect is increased in mentally retarded patients.
Szucs A; Clemens Z; Jakus R; Rásonyi G; Fabó D; Holló A; Barcs G; Kelemen A; Janszky J
Epilepsia; 2008 Jul; 49(7):1174-9. PubMed ID: 18479387
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and tolerability of levetiracetam as adjunctive therapy in Japanese patients with uncontrolled partial-onset seizures.
Inoue Y; Yagi K; Ikeda A; Sasagawa M; Ishida S; Suzuki A; Yoshida K;
Psychiatry Clin Neurosci; 2015 Oct; 69(10):640-8. PubMed ID: 25854635
[TBL] [Abstract][Full Text] [Related]
34. Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers.
Mawhinney E; Craig J; Morrow J; Russell A; Smithson WH; Parsons L; Morrison PJ; Liggan B; Irwin B; Delanty N; Hunt SJ
Neurology; 2013 Jan; 80(4):400-5. PubMed ID: 23303847
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of IV levetiracetam in children with acute repetitive seizures.
İşgüder R; Güzel O; Ağın H; Yılmaz Ü; Akarcan SE; Celik T; Ünalp A
Pediatr Neurol; 2014 Nov; 51(5):688-95. PubMed ID: 25172096
[TBL] [Abstract][Full Text] [Related]
36. Levetiracetam induced interstitial nephritis and renal failure.
Hurwitz KA; Ingulli EG; Krous HF
Pediatr Neurol; 2009 Jul; 41(1):57-8. PubMed ID: 19520278
[TBL] [Abstract][Full Text] [Related]
37. [Characteristics and indications of levetiracetam].
Herranz JL; Argumosa A
Rev Neurol; 2002 Sep; 35 Suppl 1():S110-6. PubMed ID: 12373663
[TBL] [Abstract][Full Text] [Related]
38. Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials.
Uthman BM; Almas M; Emir B; Giordano S; Leon T
Curr Med Res Opin; 2011 Jul; 27(7):1285-93. PubMed ID: 21561392
[TBL] [Abstract][Full Text] [Related]
39. Population Pharmacokinetic Modeling of Levetiracetam in Pediatric and Adult Patients With Epilepsy by Using Routinely Monitored Data.
Ito S; Yano I; Hashi S; Tsuda M; Sugimoto M; Yonezawa A; Ikeda A; Matsubara K
Ther Drug Monit; 2016 Jun; 38(3):371-8. PubMed ID: 26913593
[TBL] [Abstract][Full Text] [Related]
40. Open label, long-term, pragmatic study on levetiracetam in the treatment of juvenile myoclonic epilepsy.
Specchio LM; Gambardella A; Giallonardo AT; Michelucci R; Specchio N; Boero G; La Neve A
Epilepsy Res; 2006 Sep; 71(1):32-9. PubMed ID: 16814521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
